Grove Biopharma Closes $30 Million Series A Financing to Advance Bionic Biologics™, a New Therapeutic Modality

[#item_full_content]CHICAGO–(BUSINESS WIRE)–Grove Biopharma Closes $30 Million Series A Financing to Advance Bionic Biologics, a New Therapeutic Modality